These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Glucocorticoid hypertension due to the use of bleaching skin cream, a case report. Bwomda P; Sermijn E; Lacor P; Velkeniers B Acta Clin Belg; 2005; 60(3):146-9. PubMed ID: 16156375 [TBL] [Abstract][Full Text] [Related]
43. Development of Iatrogenic Cushing Syndrome After Peri-articular Glucocorticoid Injection in an Human Immunodeficiency Virus Patient on Protease Inhibitor Therapy. Moratalla CP; Corral JB; Núñez FD J Clin Rheumatol; 2021 Dec; 27(8S):S610-S612. PubMed ID: 30586002 [No Abstract] [Full Text] [Related]
44. Iatrogenic Cushing's syndrome in a adolescent with AIDSs on ritonavir and inhaled fluticasone. Case report and literature review. Pessanha TM; Campos JM; Barros AC; Pone MV; Garrido JR; Pone SM AIDS; 2007 Feb; 21(4):529-32. PubMed ID: 17301576 [No Abstract] [Full Text] [Related]
46. Adrenal suppression following topical use of clobetasol propionate illegally supplied as a bleaching agent. Tobin AM; Barragry J; Kirby B; O'Shea L Ir Med J; 2005 Apr; 98(4):118. PubMed ID: 15938560 [No Abstract] [Full Text] [Related]
47. The adrenal glands. Roberts A Nurs Times; 1995 Nov 8-14; 91(45):34-6. PubMed ID: 7494698 [No Abstract] [Full Text] [Related]
48. Cushing's syndrome from an inhaled glucocorticoid. Chalkley SM; Chisholm DJ Med J Aust; 1994 May; 160(10):611, 614-5. PubMed ID: 8177105 [TBL] [Abstract][Full Text] [Related]
49. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Tronche F; Kellendonk C; Kretz O; Gass P; Anlag K; Orban PC; Bock R; Klein R; Schütz G Nat Genet; 1999 Sep; 23(1):99-103. PubMed ID: 10471508 [TBL] [Abstract][Full Text] [Related]
50. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome. Stimson RH; Walker BR Minerva Endocrinol; 2007 Sep; 32(3):141-59. PubMed ID: 17912154 [TBL] [Abstract][Full Text] [Related]
51. Are the effects of local treatment with glucocorticoids only local? van Tuyl SA; Slee PH Neth J Med; 2002 Apr; 60(3):130-2. PubMed ID: 12164369 [No Abstract] [Full Text] [Related]
52. Monitoring growth in asthmatic children treated with high dose inhaled glucocorticoids does not predict adrenal suppression. Dunlop KA; Carson DJ; Steen HJ; McGovern V; McNaboe J; Shields MD Arch Dis Child; 2004 Aug; 89(8):713-6. PubMed ID: 15269067 [TBL] [Abstract][Full Text] [Related]
53. Steroid debate. Singh M; Macpherson D; Ahmed A Br Dent J; 2008 Aug; 205(3):113. PubMed ID: 18690168 [No Abstract] [Full Text] [Related]
54. Cushing's syndrome caused by short-term topical glucocorticoid use for erythrodermic psoriasis and development of adrenal insufficiency after glucocorticoid withdrawal. Durmazlar SP; Oktay B; Eren C; Eskioglu F Eur J Dermatol; 2009; 19(2):169-70. PubMed ID: 19106046 [No Abstract] [Full Text] [Related]
55. Four cases of a secondary Cushingoid state following local triamcinolone acetonide (Kenacort) injection. Jansen TL; Van Roon EN Neth J Med; 2002 Apr; 60(3):151-3. PubMed ID: 12164373 [TBL] [Abstract][Full Text] [Related]
56. [Cortisone and children]. Pelet B Rev Med Suisse Romande; 1996 Dec; 116(12):979-84. PubMed ID: 9026888 [No Abstract] [Full Text] [Related]